Trial intelligence / Profile preview

Intravenous versus intramuscular ketamine for pediatric sedation during imaging

IRCT2016021826630N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ketamine in subdural hematoma (SDH), Epidural hematoma (EDH) and subarachnoid hemorrhage (SAH) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Feb 2015; status: completed.

02

Drugs

ketamine
03

Conditions

subdural hematoma (SDH)Epidural hematoma (EDH)subarachnoid hemorrhage (SAH)

Beyond the preview

Go deeper on IRCT2016021826630N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016021826630N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call